Login to Your Account

Pharma: Other News To Note

Friday, May 4, 2012
• Novartis AG, of Basel, Switzerland, is acquiring specialty dermatology generics company Fougera Pharmaceuticals Inc., of Melville, N.Y., from a Nordic Capital-led consortium for nearly $1 .53 billion in cash. Fougera will become part of Sandoz, Novartis' generic drug division.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription